Daniel Thomas

Zealand Pharma's petrelintide shows double-digit weight loss with remarkably few side effects, positioning it to challenge GLP-1 giants in the $100B market.

With copper prices soaring, Viridian Metals is launching a major drill program to chase stunning 4.15% copper grades at its Kraken project in Labrador.

The upcoming Juneteenth closure is more than a day off. It's a window into the Postal Service's high-stakes balancing act between national duty and survival.

NTT DATA's top ranking in agentic AI reveals a market pivot from pilot projects to production-ready systems, solving the 'pilot paralysis' plaguing enterprises.

As AI sweeps through medicine, Gigi Yuen-Reed's recognition highlights a crucial strategy: building systems that empower, not replace, human expertise.

A new solution from compliance giant Avalara aims to automate tax rate management, freeing small businesses from the costly, error-prone work of manual updates.

Surf Air Mobility isn't just flying planes; it's building the AI brain to run them. Discover how its unique operator-innovator model is set to disrupt the private charter industry.

A new documentary on Soca king Machel Montano is more than a biopic. It’s a case study in building a global industry from a cultural resource.

Infrastructure AI claims its new agentic OS makes rogue AI actions 'mathematically impossible.' It’s a bold solution for a trillion-dollar problem.

Singapore's YY Group is deploying humanoid robots in hotels and malls, not to replace workers but to work with them. Is this the blueprint for the future?

A new bill aims to protect Ontario's farmland from foreign ownership, but it ignites a deeper debate on food security, urban sprawl, and economic control.

Canada injects $600M into its cultural sector while ordering a rethink of streaming rules, pitting consumer affordability against a landmark digital policy.

The men's supplement industry is shifting from pure performance to holistic vitality. A new launch reveals the economic and scientific forces driving this change.

A new global report reveals a surprising truth: as Western generosity wavers, Africa and Asia are setting a new standard, driven by community and necessity.

As Rise Therapeutics advances its oral drug R-2487, it’s not just developing another pill. It’s testing a radical new idea: resetting the immune system.

Health Union's latest awards aren't just for recognition. They're building a new strategic infrastructure for patient influence, complete with certifications.

Conning's latest report reveals a dramatic shift in U.S. state economies. While the outlook is stable, new metrics on cost and climate are separating the winners from the losers.

A strategic investment in AxisCare signals a major shift as private equity fuels AI's move from the data center to the living room, reshaping elder care.

After a period of explosive growth and a landmark IPO, StandardAero's CEO is retiring. His successor, a GE veteran, inherits a market leader facing new challenges.

A new manufacturing deal sees Bluejay Diagnostics bet on U.S. resilience. It's a strategic retreat from global risk for a firm facing a long regulatory road.